circle-image

Short

Trend Resistance

Uptrend Above: 25030

Bull Market Above: 25210
circle-image

Term

Mid Point Acts

Mid Point: 25200

Mid Range: 24680 - 25200
circle-image

View

Trend Suport

Down Trend Below: 24420

Bear Market Below: 24290
Short Term View Historic Data

Nifty View On: Monday 20 Oct 2025

Day Close

25709
Day High

25781
Day Low

25508
Day Avg

25666
17 Oct 2025
5 SMA

25398
20 SMA

25098
50 SMA

24929
100 SMA

24986
200 SMA

24230
Dhas

0.25
Macs

17.25
Dwad

0.01
Mpas

0

Monday View

Resist 2

26070
Resist 1

25980
Mid Point

25730
Suport 1

25470
Suport 2

25400
52W High

25781
52w Low

21743
52w Down

0.28%
52w Up

18.24%

Week View

Resist 2

26410
Resist 1

26230
Mid Point

25730
Suport 1

25210
Suport 2

25080
5d High

25781
5d Low

25060
10d High

25781
10d Low

24881
Days High & Low 20d High

25781
20d Low

24587
50d High

25781
50d Low

24337
All Avg

25249
Daily And Weekly Historic Prediction Data

Nifty Last Five Days Moves

SNo. Date Day Close Day High Day Low 20 DMA 50 DMA 200 DMA All Avg
1 17 Oct 2025 25709 25781 25508 25098 24929 24230 25209
2 16 Oct 2025 25585 25625 25376 25084 24908 24220 25133
3 15 Oct 2025 25323 25365 25159 25071 24891 24211 25003
4 14 Oct 2025 25145 25310 25060 25067 24876 24203 24944
5 13 Oct 2025 25227 25267 25152 25063 24868 24196 24962
Nifty Historic Data And Moving Avg

Go Back

Innova Captab Ltd is an integrated pharmaceutical company in India with a presence across the pha...

Posted: 03 Nov 2024

Innova Captab Ltd is an integrated pharmaceutical company in India with a presence across the pharmaceuticals value chain including research and development, manufacturing, drug distribution and marketing and exports. Since our inception in 2006 with a small base, we have grown strength to strength and for last more than 15 years, we are catering to top Indian pharmaceuticals companies including 10 of the top 10, and 14 of the top 15. We have license to manufacture products through two state of the art manufacturing facilities while maintaining WHO-GMP, EU-GMP and other major registrations. With the support of our world class manufacturing facilities and a reliable supply value chain, we are continuously thriving to maintain highly efficient operations. The foundation of our Company is our in-house research and development (R&D). which helps to focus on to build an increasingly complex product portfolio and attract and retain customers. We proudly possess a strong team of 1000+ employees. As a responsible corporate entity, we are been continuously endeavouring to comply with Environmental, Social & Governance compliance requirements covering the aspects of Legal compliance, ethics & business conduct, quality & patient safety, human rights, labour and employment, health safety and well-being of employees, sustainability & environmental responsibility, quality management system. Our business includes CDMO business providing research, product development and manufacturing services. We were third fastest growing CDMO in terms of Operating Income over the period Fiscal 2019 to Fiscal 2023 and positioned our Company to benefit from the growth in the CDMO market by developing strong R&D and manufacturing operations for our customers to support their domestic sales and exports to certain markets. Fourteen of the top fifteen Indian pharmaceutical companies that CRISIL Research identified as the largest players in the domestic formulation market in Fiscal 2023 have been a part of our customer base. Our Capabilities World class manufacturing facilities in Baddi, Himachal Pradesh and Our manufacturing facilities have good manufacturing practices certifications in conformity with the format recommended by WHO-GMP, EU-GMP and many other international authorities. Strong R&D focus to build an increasingly complex product portfolio and attract and retain customers Our CDMO product portfolio spans across both acute and chronic therapeutic areas Leading presence and one of the fastest growing CDMOs in the Indian pharmaceutical formulations market Well established relationships with our marquee CDMO customer base Our strength in CDMO sphere includes: Our comprehensive CDMO formulation capabilities allow us to offer our customers multiple dosage forms, including oral solids, oral liquids, dry syrups and injectables, as well as more complex delivery forms such as modified and sustained release forms and tablets in capsules. We manufacture products that are in all the top ten therapeutic areas by sales in the Indian formulation market in Fiscal 2023 as identified by CRISIL Research. We manufacture products across some of the key therapeutic areas. Our operational track record in successful delivery of products, R&D, quality and technical standards and productivity Strong R&D and manufacturing operations for our customers to support their domestic sales and exports to certain markets. Our R&D laboratory is equipped with the entire suite of necessary equipment for the development of solid oral and liquid dosage forms Domestic Branded Generics Our Branded Generics business consists of the development, manufacture and distribution of generic formulation products, which are marketed and distributed in India under our own brand names through online and offline channels. Our branded generic products are generic medicines for which the patents have expired, that are sold directly to our distributors, stockists & retailers. We sell our domestic branded generic products through our pan-Indian network of distributors, stockists and pharmacies. Our generic drug products are also available online through various e-commerce pharmacy sites. We have developed a diversified branded generics product portfolio including Tablets, capsules, dry syrups, dry powder injection, ointments and liquid orals

Market Bits

"In investing, what is comfortable is rarely profitable." — Robert Arnott

Be prepared to invest in a down market and to "get out" in a soaring market, as per the philosophy of Warren Buffett.